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Abstract
Aim. In patients with malignant hilar obstruction, liver resection is associated with an increased risk of postoperative liver
failure attributed to the need for major liver resection in a context of obstructive jaundice. To overcome this issue, most
authors recommend preoperative biliary drainage (PBD). However, PBD carries risks of its own, including, primarily, sepsis
and, more rarely, tumor seeding, bile peritonitis, and hemobilia. We, unlike most authors, have not used routine PBD before
liver resection in jaundiced patients. Material and methods. Our series includes 62 patients who underwent major liver
resection for cholangiocarcinoma; 33 of these had elevated bilurubin (60470 mmol/l) and were operated without PBD.
There were 43 extended right hepatectomies and 18 extended left hepatectomies. Results. Hospital deaths occurred in
5 patients (8%) including 3 of 33 jaundiced patients (9%, ns). All deaths occurred after extended right hepatectomy (12%),
including 3 patients with a serum bilirubin level above 300 mmol/l and 2 with normal bilirubin. There were no deaths after
left-sided resections, whatever the level of bilirubin. Conclusions. PBD can be omitted in the following situations: recent
onset jaundice (B23 weeks), total bilirubinB200 mmol/l, no previous endoscopic or transhepatic cholangiography, absence
of sepsis, future liver remnant40%. These criteria include most patients requiring left-sided resections and selected
patients requiring right-sided resections. In other cases, PBD is required, associated with portal vein embolization in the
event of a small future liver remnant.
Introduction
Liver resections in jaundiced patients are associated
with significant rates of mortality and morbidity due
mainly to the development of postoperative liver
failure. Therefore, preparation for surgery by pre-
operative biliary drainage (PBD) has been advocated
before definitive surgery with the aim of reducing
morbidity and mortality [14]. More recently, induc-
tion of hypertrophy of the remaining liver by portal
vein embolization has also become a frequent part of
preparation for surgery [5]. However, PBD is asso-
ciated with complications of its own that may reduce
its benefits substantially. These include mainly sepsis
but also tumor seeding along biliary drain tracts.
Benefit
Five level-1 prospective randomized trials of preo-
perative PBD, including more than 300 patients, have
failed to demonstrate a survival benefit of PBD, while
all 5 showed increased morbidity and hospital stay
with PBD [610]. A meta-analysis of these studies by
Sewnath et al. has confirmed individual analysis of
each paper [11]. In the same study, meta-analysis of
18 additional level-2 studies (non-randomized cohort
comparisons) including close to 3000 patients showed
the same lack of benefit and confirmed increased
morbidity. When PBD-induced complications were
removed from analysis, PBD was associated with a
benefit. However, these trials included patients with
various benign and malignant diseases, and most
malignant lesions were located in the distal portion
of the bile duct. Consequently, very few patients in
these studies underwent liver resection. These studies
clearly indicated that PBD was associated with
specific complications which could outweigh the
potential benefits of this technique.
Complications
Sepsis is the main complication of PBD [15,12].
Cholangitis after PBD has been reported in 2060%
of cases and may compromise subsequent surgery
with patient dropout. Intraoperative bile cultures have
been found to be positive in 65% of patients with
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PBD, while the rate was 8% in patients without PBD.
This may be associated with increased postoperative
infections such as wound or intraperitoneal abscesses.
Implantation metastases can occur in up to 6% of
cases after transhepatic PBD [13]. Peritoneal and
pleural metastases have also been reported. These
complications clearly compromise the oncologic re-
sults of such procedures. Finally, bile peritonitis and
hemobilia are other complications reported in asso-
ciation with PBD.
Specific indications
Despite these drawbacks and because liver resections
in jaundiced patients are considered to carry a special
risk, most authors continue to recommend PBD
before resection of hilar cholangiocarcinoma.
In the absence of demonstrated benefits of PBD,
our policy in patients undergoing liver resection for
high malignant obstructive stricture has been to avoid
systematic PBD. Direct cholangiography, either per-
cutaneous or endoscopic, in jaundiced patients re-
quires subsequent biliary drainage and therefore
should be avoided prior to patient referral. This is
possible with modern imaging, including MDCT and
MRCP. Because we do not use routine PBD, we
attempt to schedule surgery in patients with obstruc-
tive jaundice due to proximal bile duct cancer as
quickly as possible. Our policy is to perform non-
invasive preoperative imaging work-up followed by
laparotomy in the same week.
Personal experience
In order to identify specific complications observed in
jaundiced patients undergoing major liver resection,
we undertook a case control study comparing mor-
bidity and morbidity after liver resection in undrained
jaundiced patients and matched patients without
biliary obstruction [14]. Our study showed that there
were no differences for liver failure and mortality rates
after liver resection in jaundiced and non-jaundiced
patients. However, transfusion requirements and
morbidity rate were significantly higher in patients
with obstructive jaundice. Significant differences in
postoperative complications included bile leaks and
subphrenic abcesses, which occurred more frequently
in jaundiced patients and accounted for increased
hospital stay. The overall morbidity rate of 50% after
liver resection in jaundiced patients was significantly
higher than the 15% observed in non-jaundiced
patients. This is probably secondary to dilatation of
intrahepatic bile ducts and opening the intestinal
tract. However, the incidence of bile leaks and
subphrenic collections compared with those reported
in patients having undergone PBD in whom bile
infection secondary to PBD might represent an
additional risk factor.
In the same study, the rate of liver failure in
jaundiced patients was low (5%) and recovery of liver
synthetic function, assessed by prothrombin activity,
was identical to that of non-jaundiced patients. The
mortality rate of 5% was also comparable to that
reported after liver resection following PBD. Update
of our series included 62 patients who had resection of
hilar cholangiocarcinoma (Figure 1). Of these, 33
(52%) had a bilirubin level higher than 3 times the
upper normal value at the time of surgery. All patients
underwent major resection, including extended right
hepatectomy in 43 cases and extended left in 18
(Figure 2). There were 5 deaths (8%) (Figure 3). All
deaths occurred after extended right hepatectomy,
including 3 patients with a serum bilirubin level above
300 mmol/l and 2 with normal bilirubin (Figure 4).
There was no death after extended left hepatectomy,
although this group included a majority of jaundiced,
several with a bilirubin above 300 mmol/l (Figure 5).
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Figure 1. Updated series: 62 patients with cholangiocarcinoma.
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Figure 2. Operations performed.
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While we do not recommend routine use of PBD,
there are cases where it is required. These are patients
with a future liver remnant of less than 40% of total
volume, those with cholangitis, long-standing jaun-
dice, denutrition and hypoalbuminemia.
If PBD is used, it should drain the future remnant
liver, and surgery should be scheduled after bilirubin
is below twice the normal value. In the event of
cholangitis or long duration drainage, PBD tubes
should be changed. When the future remnant liver is
deemed too small, preoperative portal vein emboliza-
tion is indicated to induce hypertrophy of the future
remnant liver, and preliminary PBD is required.
Conclusions
In conclusion, PBD is associated with specific com-
plications, including sepsis and to a lesser extent,
tumor seeding. It should not be performed system-
atically and specialized surgical evaluation should be
performed before any type of direct cholangiography
or PBD is performed.
PBD can be omitted in the following situations:
recent onset jaundice (B23 weeks), total bilirubin
B200 mmol/l, absence of sepsis, future liver rem-
nant40%.
These criteria include most patients requiring left-
sided resections and selected patients requiring right-
sided resections. In other cases, PBD is required,
associated with portal vein embolization in the event
of a small future liver remnant.
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Figure 3. Hospital mortality of the global series.
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Figure 4. Hospital mortality of extended right hepatectomies.
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Figure 5. Hospital mortality of extended left hepatectomies.
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